Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chez les sujets avec insuffisance cardiaque à fraction d’éjection diminuée avec ou sans diabète de type 2, est-ce que la dapagliflozine, un inhibiteur des SGLT2, est efficace pour prévenir l’insuffisance cardiaque décompensée ou la mortalité cardiovasculaire tout en étant sécuritaire ?
Lanthier L, Dussault C, Huard G, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: cauchon m. Rev Med Interne. 2020 Feb;41(2):143-144. doi: 10.1016/j.revmed.2019.12.011. Epub 2020 Jan 9. Rev Med Interne. 2020. PMID: 31928796 French. No abstract available.
[In ambulatory patients with suspected pulmonary embolism, does a new diagnostic strategy using D-dimers adjusted to clinical probability make it possible to safely exclude this diagnosis without using chest imaging?].
Lanthier L, Le Templier G, Huard G, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: cauchon m. Rev Med Interne. 2020 Jun;41(6):429-430. doi: 10.1016/j.revmed.2020.03.005. Epub 2020 Jun 1. Rev Med Interne. 2020. PMID: 32499058 French. No abstract available.
[Among patients with stable coronary disease and moderate or severe ischemia, does coronary angiography and revascularization when possible plus optimal medical treatment result in better clinical outcomes compared with optimal medical therapy alone?].
Lanthier L, Huard G, Plourde MÉ, Cauchon M. Lanthier L, et al. Among authors: cauchon m. Rev Med Interne. 2020 Jul;41(7):504-505. doi: 10.1016/j.revmed.2020.06.007. Epub 2020 Jul 14. Rev Med Interne. 2020. PMID: 32674897 French. No abstract available.
[In patient with symptomatic peripheral arterial disease who had undergone lower-extremity revascularization, does rivaroxaban 2.5 mg twice daily plus aspirin reduce the composite risk of acute limb ischemia, major amputation for vascular causes, myocardial infarction, ischemic stroke or cardiovascular death compared to aspirin alone while being safe?].
Lanthier L, Huard G, Plourde ME, Cauchon M. Lanthier L, et al. Among authors: cauchon m. Rev Med Interne. 2020 Aug;41(8):571-572. doi: 10.1016/j.revmed.2020.07.004. Epub 2020 Aug 12. Rev Med Interne. 2020. PMID: 32798088 French. No abstract available.
59 results